122 related articles for article (PubMed ID: 23385514)
1. Immunohistochemical expression of Skp2 protein in oral nevi and melanoma.
Benevenuto-de-Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; Paes-de-Almeida O
Med Oral Patol Oral Cir Bucal; 2013 May; 18(3):e388-91. PubMed ID: 23385514
[TBL] [Abstract][Full Text] [Related]
2. Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma.
de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
Ann Diagn Pathol; 2013 Feb; 17(1):32-6. PubMed ID: 22652151
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.
de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
Head Neck Pathol; 2012 Sep; 6(3):297-304. PubMed ID: 22311377
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
[TBL] [Abstract][Full Text] [Related]
5. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
PLoS One; 2011 Feb; 6(2):e17578. PubMed ID: 21386910
[TBL] [Abstract][Full Text] [Related]
7. Expression of fatty acid synthase (FASN) in oral nevi and melanoma.
de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; Graner E; de Almeida OP
Oral Dis; 2011 Nov; 17(8):808-12. PubMed ID: 21819495
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression in melanocytic lesions of the skin.
YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
10. A multi-marker assay to distinguish malignant melanomas from benign nevi.
Kashani-Sabet M; Rangel J; Torabian S; Nosrati M; Simko J; Jablons DM; Moore DH; Haqq C; Miller JR; Sagebiel RW
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6268-72. PubMed ID: 19332774
[TBL] [Abstract][Full Text] [Related]
11. DEK expression in melanocytic lesions.
Kappes F; Khodadoust MS; Yu L; Kim DS; Fullen DR; Markovitz DM; Ma L
Hum Pathol; 2011 Jul; 42(7):932-8. PubMed ID: 21316078
[TBL] [Abstract][Full Text] [Related]
12. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
13. PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus.
Kanoko M; Ueda M; Ichihashi M
Kobe J Med Sci; 1994 Aug; 40(3-4):107-23. PubMed ID: 7739200
[TBL] [Abstract][Full Text] [Related]
14. Expression of Skp2 and p27KIP1 in naevi and malignant melanoma of the skin and its relation to clinical outcome.
Woenckhaus C; Maile S; Uffmann S; Bansemir M; Dittberner T; Poetsch M; Giebel J
Histol Histopathol; 2005 Apr; 20(2):501-8. PubMed ID: 15736055
[TBL] [Abstract][Full Text] [Related]
15. Expression of p-27 (kip1) in nevi and melanomas.
Morgan MB; Cowper SE
Am J Dermatopathol; 1999 Apr; 21(2):121-4. PubMed ID: 10218670
[TBL] [Abstract][Full Text] [Related]
16. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
17. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]